Characterization of recombinant Raccoonpox Vaccine Vectors in Chickens

Avian Diseases

Volumn 54, Issue 4, 2010, Pages 1157-1165

  Hwa, Shi Hsia ^a   Iams, Keith P ^a,c   Hall, Jeffrey S ^b   Kingstad, Brock A ^a   Osorio, Jorge E ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b NATIONAL WILDLIFE HEALTH CENTER   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

avian influenza; bioluminescence; in vivo imaging; mammalianpox virus; raccoonpox virus; vaccine vector

Indexed keywords

HEMAGGLUTININ; INFLUENZA VACCINE; VIRUS VACCINE;

ANIMAL; ARTICLE; AVIAN INFLUENZA; CELL CULTURE; CHICK EMBRYO; CHICKEN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FIBROBLAST; GENE EXPRESSION REGULATION; GENE VECTOR; IMMUNOLOGY; INFLUENZA VIRUS A H5N1; METABOLISM; POXVIRUS; VIROLOGY; VIRUS CULTURE;

ANIMALS; CELLS, CULTURED; CHICK EMBRYO; CHICKENS; FIBROBLASTS; GENE EXPRESSION REGULATION, VIRAL; GENETIC VECTORS; HEMAGGLUTININS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; POXVIRIDAE; VIRAL VACCINES; VIRUS CULTIVATION;

AVES; AVIAN INFLUENZA VIRUS; GALLUS GALLUS; MAMMALIA; ORTHOMYXOVIRIDAE; RACCOONPOX VIRUS;

EID: 78650481156     PISSN: 00052086     EISSN: None     Source Type: Journal    
DOI: 10.1637/9315-032410-Reg.1     Document Type: Article

References (57)

1. Alexander, A. D., V. Flyger, Y. F. Herman, S. J. McConnell, N. Rothstein, and R. H. Yager. Survey of wild mammals in a Chesapeake Bay area for selected zoonoses. J. Wildl. Dis. 8:119-126. 1972.
2. Andrew, M. E., B. E. H. Coupar, and D. B. Boyle. Immunogenicity and antigen presentation In: Recombinant poxviruses. M. M. Binns and G. Smith, eds. CRC Press, Boca Raton, FL. pp. 207-234. 1992.
3. Blanton, J. D., J. Self, M. Niezgoda, M. L. Faber, B. Dietzschold, and C. Rupprecht. Oral vaccination of raccoons (Procyon lotor) with genetically modified rabies virus vaccines. Vaccine 25:7296-7300. 2007.
4. Bright, R. A., D. M. Carter, C. J. Crevar, F. R. Toapanta, J. D. Steckbeck, K. S. Cole, N. M. Kumar, P. Pushko, G. Smith, T. M. Tumpey, and T. M. Ross. Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle. PLoS One 3(1):e1501. 2008.
5. Bublot, M., F. X. Le Gros, D. Nieddu, N. Pritchard, T. R. Mickle, and D. E. Swayne. Efficacy of two H5N9-inactivated vaccines against challenge with a recent H5N1 highly pathogenic avian influenza isolate from a chicken in Thailand. Avian Dis. 51:332-337. 2007.
6. Bublot, M., N. Pritchard, D. E. Swayne, P. Selleck, K. Karaca, D. L. Suarez, J. C. Audonnet, and T. R. Mickle. Development and use of fowlpox vectored vaccines for avian influenza. Ann. N. Y. Acad. Sci. 1081:193-201. 2006.
7. Capua, I., and G. Cattoli. Diagnosing avian influenza infection in vaccinated populations by systems for differentiating infected from vaccinated animals (DIVA). Dev. Biol. (Basel) 130:137-143. 2007.
8. Chakrabarti, S., J. R. Sisler, and B. Moss. Compact, synthetic, vaccinia virus early/late promoter for protein expression. Biotechniques 23:1094-1097. 1997.
9. Cottingham, M. G., R. F. Andersen, A. J. Spencer, S. Saurya, J. Furze, A. V. Hill, and S. C. Gilbert. Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA). PLoS One 3(2):e1638. doi:10.1371/journal.pone. 0001638. 2008.
10. DeMartini, J. C., H. M. Bickle, S. J. Brodie, B. X. He, and J. J. Esposito. Raccoon poxvirus rabies virus glycoprotein recombinant vaccine in sheep. Arch. Virol. 133:211-222. 1993.
11. Dothager, R. S., K. Flentie, B. Moss, M. H. Pan, A. Kesarwala, and D. Piwnica-Worms. Advances in bioluminescence imaging of live animal models. Curr. Opin. Biotechnol. 20:45-53. 2009.
12. El Garch, H., J. M. Minke, J. Rehder, S. Richard, C. Edlund Toulemonde, S. Dinic, C. Andreoni, J. C. Audonnet, R. Nordgren, and V. Juillard. A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse. Vet. Immunol. Immunopathol. 123:230-239. 2008.
13. Elroy-Stein, O., and B. Moss. Gene expression using the vaccinia virus/T7 RNA polymerase hybrid system. Curr. Protoc. Mol. Biol. May, Chapter 16:Unit16:19. 2001.
14. Falkner, F. G., and B. Moss. Transient dominant selection of recombinant vaccinia viruses. J. Virol. 64:3108-3111. 1990.
15. Fatunmbi, O. O., J. A. Newman, D. A. Halvorson, and V. Sivanandan. Effect of temperature on the stability of avian influenza virus antigens under different storage conditions. Avian Dis. 37:639-646. 1993.
16. Fauci, A. S. Pandemic influenza threat and preparedness. Emerg. Infect. Dis. 12:73-77. 2006.
17. Fenner, F. Vaccinia virus as a vaccine and poxvirus pathogenesis. In: Recombinant poxviruses. M. M. Binns and G. L. Smith, eds. CRC Press, Boca Raton, FL. pp. 1-44. 1992.
18. Gilbert, S. C., V. S. Moorthy, L. Andrews, A. A. Pathan, S. J. McConkey, J. M. Vuola, S. M. Keating, T. Berthoud, D. Webster, H. McShane, and A. V. Hill. Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosis. Vaccine 24:4554-4561. 2006.
19. Gomez, C. E., J. L. Najera, E. Domingo-Gil, L. Ochoa-Callejero, G. Gonzalez-Aseguinolaza, and M. Esteban. Virus distribution of the attenuated MVA and NYVAC poxvirus strains in mice. J. Gen. Virol. 88:2473-2478. 2007.
20. Hehme, N., T. Colegate, B. Palache, and L. Hessel. Influenza vaccine supply: building long-term sustainability. Vaccine 26(Suppl. 4):D23-D26. 2008.
21. Hehme, N., H. Engelmann, W. Kunzel, E. Neumeier, and R. Sanger. Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines. Med. Microbiol. Immunol. 191:203-208. 2002.
22. Herman, Y. F. Isolation and characterization of a naturally occurring poxvirus of raccoons. 64th Bacteriological Proceedings, American Society for Microbiology, Washington, DC. p. 117. 1964.
23. Hu, L., C. Ngichabe, C. V. Trimarchi, J. J. Esposito, and F. W. Scott. Raccoon poxvirus live recombinant feline panleukopenia virus VP2 and rabies virus glycoprotein bivalent vaccine. Vaccine 15:1466-1472. 1997.
24. Ichinohe, T., A. Iwasaki, and H. Hasegawa. Innate sensors of influenza virus: clues to developing better intranasal vaccines. Expert Rev. Vaccines 7:1435-1445. 2008.
25. Johnston, P. A., H. Liu, T. O'Connell, P. Phelps, M. Bland, J. Tyczkowski, A. Kemper, T. Harding, A. Avakian, E. Haddad, C. Whitfill, R. Gildersleeve, and C. A. Ricks. Applications in in ovo technology. Poult. Sci. 76:165-178. 1997.
26. Krauss, O., R. Hollinshead, M. Hollinshead, and G. L. Smith. An investigation of incorporation of cellular antigens into vaccinia virus particles. J. Gen. Virol. 83:2347-2359. 2002.
27. Larson, L. J., and R. D. Schultz. Three-year duration of immunity in dogs vaccinated with a canarypox-vectored recombinant canine distemper virus vaccine. Vet. Ther. 8:101-106. 2007.
28. Lillehoj, H. S., X. Ding, M. A. Quiroz, E. Bevensee, and E. P. Lillehoj. Resistance to intestinal coccidiosis following DNA immunization with the cloned 3-1E Eimeria gene plus IL-2, IL-15, and IFN-gamma. Avian Dis. 49:112-117. 2005.
29. Lodmell, D. L., J. W. Sumner, J. J. Esposito, W. J. Bellini, and L. C. Ewalt. Raccoon poxvirus recombinants expressing the rabies virus nucleoprotein protect mice against lethal rabies virus infection. J. Virol. 65:3400-3405. 1991.
30. Meltzer, M. I., N. J. Cox, and K. Fukuda. The economic impact of pandemic influenza in the United States: priorities for intervention. Emerg. Infect. Dis. 5:659-671. 1999.
31. Mencher, J. S., S. R. Smith, T. D. Powell, D. T. Stinchcomb, J. E. Osorio, and T. E. Rocke. Protection of black-tailed prairie dogs (Cynomys ludovicianus) against plague after voluntary consumption of baits containing recombinant raccoon poxvirus vaccine. Infect. Immun. 72:5502-5505. 2004.
32. Moss, B. Molecular biology of poxviruses. In: Recombinant poxviruses. M. M. Binns and G. L. Smith, eds. CRC Press, Boca Raton, FL. pp. 45-80. 1992.
33. Murakami, S., T. Horimoto, Q. Mai le, C. A. Nidom, H. Chen, Y. Muramoto, S. Yamada, A. Iwasa, K. Iwatsuki-Horimoto, M. Shimojima, A. Iwata, and Y. Kawaoka. Growth determinants for H5N1 influenza vaccine seed viruses in MDCK cells. J. Virol. 82:10,502-10,509. 2008.
34. Osorio, J. E., R. S. Frank, K. Moss, T. Taraska, T. Powell, and D. T. Stinchcomb. Raccoon poxvirus as a mucosal vaccine vector for domestic cats. J. Drug Target 11:463-470. 2003.
35. Osorio, J. E., K. P. Iams, C. U. Meteyer, and T. E. Rocke. Comparison of monkeypox viruses pathogenesis in mice by in vivo imaging. PLoS One 4(8):e6592. 2009.
36. Pan, Z., X. Zhang, S. Geng, N. Cheng, L. Sun, B. Liu, J. Huang, and X. Jiao. Priming with a DNA vaccine delivered by attenuated Salmonella typhimurium and boosting with a killed vaccine confers protection of chickens against infection with the H9 subtype of avian influenza virus. Vaccine 27:1018-1023. 2009.
37. Paoletti, E. Applications of pox virus vectors to vaccination: an update. Proc. Natl. Acad. Sci. U. S. A. 93:11,349-11,353. 1996.
38. Ramirez, J. C., D. Finke, M. Esteban, J. P. Kraehenbuhl, and H. Acha-Orbea. Tissue distribution of the Ankara strain of vaccinia virus (MVA) after mucosal or systemic administration. Arch. Virol. 148:827-839. 2003.
39. Rocke, T. E., S. R. Smith, D. T. Stinchcomb, and J. E. Osorio. Immunization of black-tailed prairie dog against plague through consumption of vaccine-laden baits. J. Wildl. Dis. 44:930-937. 2008.
40. Ropp, S. L., Q. Jin, J. C. Knight, R. F. Massung, and J. J. Esposito. PCR strategy for identification and differentiation of small pox and other orthopoxviruses. J. Clin. Microbiol. 33:2069-2076. 1995.
41. Sharma, J. M., Y. Zhang, D. Jensen, S. Rautenschlein, and H. Y. Yeh. Field trial in commercial broilers with a multivalent in ovo vaccine comprising a mixture of live viral vaccines against Marek's disease, infectious bursal disease, Newcastle disease, and fowl pox. Avian Dis. 46:613-622. 2002.
42. Shi, H., X. F. Liu, X. Zhang, S. Chen, L. Sun, and J. Lu. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses. Vaccine 25:7379-7384. 2007.
43. Skinner, M. A., S. M. Laidlaw, I. Eldaghayes, P. Kaiser, and M. G. Cottingham. Fowlpox virus as a recombinant vaccine vector for use in mammals and poultry. Expert Rev. Vaccines 4:63-76. 2005.
44. Spatz, S. J., P. A. Rota, and R. K. Maes. Identification of the feline herpesvirus type 1 (FHV-1) genes encoding glycoproteins G, D, I and E: expression of FHV-1 glycoprotein D in vaccinia and raccoon poxviruses. J. Gen. Virol. 75(Pt. 6):1235-1244. 1994.
45. Suarez, D. L., C. W. Lee, and D. E. Swayne. Avian influenza vaccination in North America: strategies and difficulties. Dev. Biol. (Basel) 124:117-124. 2006.
46. Suarez, D. L., and S. Schultz-Cherry. Immunology of avian influenza virus: a review. Dev. Comp. Immunol. 24:269-283. 2000.
47. Swayne, D. E. Principles for vaccine protection in chickens and domestic waterfowl against avian influenza: emphasis on Asian H5N1 high pathogenicity avian influenza. Ann. N. Y. Acad. Sci. 1081:174-181. 2006.
48. Swayne, D. E., J. R. Beck, and N. Kinney. Failure of a recombinant fowl poxvirus vaccine containing an avian influenza hemagglutinin gene to provide consistent protection against influenza in chickens preimmunized with a fowl pox vaccine. Avian Dis. 44:132-137. 2000.
49. Taylor, J., R. Weinberg, J. Tartaglia, C. Richardson, G. Alkhatib, D. Briedis, M. Appel, E. Norton, and E. Paoletti. Nonreplicating viral vectors as potential vaccines: recombinant canarypox virus expressing measles virus fusion (F) and hemagglutinin (HA) glycoproteins. Virology 187:321-328. 1992.
50. Tewalt, E. F., J. M. Grant, E. L. Granger, D. C. Palmer, N. D. Heuss, D. S. Gregerson, N. P. Restifo, and C. C. Norbury. Viral sequestration of antigen subverts cross presentation to CD8(+) T cells. PLoS Pathog. 5(5):e1000457. doi:10.1371/journal.ppat.1000457. 2009.
51. Thomas, E. K., E. L. Palmer, J. F. Obijeski, and J. H. Nakano. Further characterization of raccoonpox virus. Arch. Virol. 49:217-227. 1975.
52. van Ginkel, F. W., D. C. Tang, S. L. Gulley, and H. Toro. Induction of mucosal immunity in the avian Harderian gland with a replication-deficient Ad5 vector expressing avian influenza H5 hemagglutinin. Dev. Comp. Immunol. 33:28-34. 2009.
53. Veits, J., A. Romer-Oberdorfer, D. Helferich, M. Durban, Y. Suezer, G. Sutter, and T. C. Mettenleiter. Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions. Vaccine 26:1688-1696. 2008.
54. Wasmoen, T. L., N. P. Kadakia, R. C. Unfer, B. L. Fickbohm, C. P. Cook, H. J. Chu, and W. M. Acree. Protection of cats from infectious peritonitis by vaccination with a recombinant raccoon poxvirus expressing the nucleocapsid gene of feline infectious peritonitis virus. Adv. Exp. Med. Biol. 380:221-228. 1995.
55. Weli, S. C., O. Nilssen, and T. Traavik. Avipoxvirus multiplication in a mammalian cell line. Virus Res. 109:39-49. 2005.
56. World Health Organization. H5N1 avian influenza: timeline of major events. In: Global alert and response (GAR). World Health Organization, Geneva. 2010.
57. World Organisation for Animal Health (OIE). Avian influenza. In: Manual of diagnostic tests and vaccines for terrestrial animals 2009. OIE, Paris. pp. 1-20. 2009.